招商輪船(601872.SH):終止分拆子公司重組上市
格隆匯5月27日丨招商輪船(601872.SH)公佈,招商輪船原擬分拆所屬子公司中外運集運、招商滾裝,通過與安通控股進行重組的方式實現重組上市,即安通控股向公司發行股份購買公司持有的中外運集運100%股權和招商滾裝70%股權。自本次交易事項籌劃以來,公司嚴格按照相關法律法規及規範性文件要求,積極組織相關各方推進本次交易工作。但鑑於交易各方尚未就交易條款等相關事項協商一致,且考慮到本次交易事項自籌劃以來歷時較長,當前市場環境及標的公司實際情況較本次交易籌劃初期已發生一定變化,爲切實維護上市公司和廣大投資者長期利益,經公司與相關各方充分溝通及友好協商,基於審慎性考慮,公司決定終止本次交易事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.